The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C02 | Antihypertensives | |
| 3 | C02D | Arteriolar smooth muscle, agents acting on | |
| 4 | C02DD | Nitroferricyanide derivatives |
| Code | Title | |
|---|---|---|
| C02DD01 | Nitroprusside |
| Active Ingredient | Description | |
|---|---|---|
| Nitroprusside |
The principal pharmacological action of nitroprusside is relaxation of vascular smooth muscle and consequent dilation of peripheral arteries and veins. Other smooth muscle (e.g. uterus, duodenum) is not affected. Nitroprusside is more active on veins than on arteries. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| NIPRIDE RTU Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NITROPRESS Solution for injection, concentrate | FDA, National Drug Code (US) | MPI, US: SPL/Old |
